- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabis for the Treatment of Epilepsy: an Update
Authors
Keywords
Epilepsy, Lennox-Gastaut syndrome, Dravet syndrome, Cannabis, Cannabidiol, Tetrahydrocannabinol, Interactions, Mechanism of action, Efficacy
Journal
Current Neurology and Neuroscience Reports
Volume 18, Issue 11, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-08
DOI
10.1007/s11910-018-0882-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of CBD-enriched medical cannabis for treatment of refractory epilepsy in children and adolescents – An observational, longitudinal study
- (2018) Moran Hausman-Kedem et al. BRAIN & DEVELOPMENT
- Positron emission tomography imaging of cerebral glucose metabolism and type 1 cannabinoid receptor availability during temporal lobe epileptogenesis in the amygdala kindling model in rhesus monkeys
- (2018) Evy Cleeren et al. EPILEPSIA
- Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results
- (2018) Jerzy P. Szaflarski et al. EPILEPSIA
- Open-label use of Highly* purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes
- (2018) Orrin Devinsky et al. EPILEPSY & BEHAVIOR
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome
- (2018) Orrin Devinsky et al. NEUROLOGY
- Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
- (2018) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
- (2018) Jerzy P. Szaflarski et al. EPILEPSY & BEHAVIOR
- Composition and Use of Cannabis Extracts for Childhood Epilepsy in the Australian Community
- (2018) A. Suraev et al. Scientific Reports
- Interactions between cannabidiol and commonly used antiepileptic drugs
- (2017) Tyler E. Gaston et al. EPILEPSIA
- An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use
- (2017) Anastasia S. Suraev et al. EPILEPSY & BEHAVIOR
- Assessing the role of serotonergic receptors in cannabidiol's anticonvulsant efficacy
- (2017) Madeline C. Pelz et al. EPILEPSY & BEHAVIOR
- Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels
- (2017) Luciano R. Vilela et al. EPILEPSY & BEHAVIOR
- Pharmacology of cannabinoids in the treatment of epilepsy
- (2017) Tyler E. Gaston et al. EPILEPSY & BEHAVIOR
- The current status of artisanal cannabis for the treatment of epilepsy in the United States
- (2017) Dustin Sulak et al. EPILEPSY & BEHAVIOR
- A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity
- (2017) Katrina Hurst et al. HIPPOCAMPUS
- Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid
- (2017) Ewa Kozela et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome
- (2017) Joshua S. Kaplan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol
- (2016) Reesha R. Patel et al. BRAIN
- Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex
- (2016) Evan J. Hess et al. EPILEPSIA
- Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases
- (2016) Jacqueline S. Gofshteyn et al. JOURNAL OF CHILD NEUROLOGY
- Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial
- (2016) Orrin Devinsky et al. LANCET NEUROLOGY
- CBD-enriched medical cannabis for intractable pediatric epilepsy
- (2016) Michal Tzadok et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
- (2015) John M McPartland et al. BRITISH JOURNAL OF PHARMACOLOGY
- TRPV1 Channel: A Potential Drug Target for Treating Epilepsy
- (2015) Mustafa Nazıroglu Current Neuropharmacology
- Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
- (2015) Alexandra L. Geffrey et al. EPILEPSIA
- Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox–Gastaut syndrome
- (2015) Shaun A. Hussain et al. EPILEPSY & BEHAVIOR
- Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy
- (2015) Craig A. Press et al. EPILEPSY & BEHAVIOR
- Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products
- (2015) Ryan Vandrey et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Placebo effect of medication cost in Parkinson disease: A randomized double-blind study
- (2015) A. J. Espay et al. NEUROLOGY
- The case for medical marijuana in epilepsy
- (2014) Edward Maa et al. EPILEPSIA
- Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders
- (2014) Orrin Devinsky et al. EPILEPSIA
- Cannabis, cannabidiol, and epilepsy — From receptors to clinical response
- (2014) Jerzy P. Szaflarski et al. EPILEPSY & BEHAVIOR
- Cannabidiol Is a Potent Inhibitor of the Catalytic Activity of Cytochrome P450 2C19
- (2013) Rongrong Jiang et al. Drug Metabolism and Pharmacokinetics
- Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death
- (2013) N Rimmerman et al. Cell Death & Disease
- Inhibition of Recombinant Human T-type Calcium Channels by Δ9-Tetrahydrocannabinol and Cannabidiol
- (2008) Hamish Redmond Ross et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
- (2007) R G Pertwee BRITISH JOURNAL OF PHARMACOLOGY
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
- (2007) A Thomas et al. BRITISH JOURNAL OF PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More